Protagonist Therapeutics Inc buy Capital One Financial Co.
Start price
30.10.23
/
50%
€84.50
Target price
30.10.24
€30.16
Performance (%)
-
End price
31.10.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -5.587% | -5.587% | 130.874% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by Capital_One_Financia for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $32.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Capital_One_Financia gewählte maximale Laufzeit wurde überschritten